Symbol="ADPT"
AssetType="Common Stock"
Name="Adaptive Biotechnologies Corp"
Description="Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington."
CIK="1478320"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="927102000"
EBITDA="-166283008"
PERatio="None"
PEGRatio="0"
BookValue="2.738"
DividendPerShare="0"
DividendYield="0"
EPS="-1.34"
RevenuePerShareTTM="1.321"
ProfitMargin="-1.007"
OperatingMarginTTM="-0.992"
ReturnOnAssetsTTM="-0.15"
ReturnOnEquityTTM="-0.418"
RevenueTTM="189601000"
GrossProfitTTM="-13657000"
DilutedEPSTTM="-1.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.121"
AnalystTargetPrice="11.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.64"
PriceToBookRatio="2.436"
EVToRevenue="4.698"
EVToEBITDA="-3.906"
Beta="1.179"
num_52WeekHigh="10.79"
num_52WeekLow="5.96"
num_50DayMovingAverage="7.17"
num_200DayMovingAverage="7.93"
SharesOutstanding="144311000"
DividendDate="None"
ExDividendDate="None"
symbol="ADPT"
open="6.09"
high="6.25"
low="6.04"
price="6.16"
volume="1136655.00"
latest_trading_day="2023-08-25"
previous_close="6.07"
change="0.09"
change_percent="1.4827%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="57"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="1065732"
Change_recent_avg="-0.03"
Delta_recent_avg="0.42"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-0.42"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="107"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0069.jpeg"
image_negative_thumbnail_id_2="113"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0063.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="581"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_positive_thumbnail_id_1="642"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_positive_thumbnail_id_2="605"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
